These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11459079)

  • 1. Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design.
    Linday LA; Tsiouris JA; Cohen IL; Shindledecker R; DeCresce R
    J Neural Transm (Vienna); 2001; 108(5):593-611. PubMed ID: 11459079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral famotidine: a potential treatment for children with autism.
    Linday LA
    Med Hypotheses; 1997 May; 48(5):381-6. PubMed ID: 9185122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of histamine 2 receptor antagonism in treatment-resistant schizophrenia.
    Meskanen K; Ekelund H; Laitinen J; Neuvonen PJ; Haukka J; Panula P; Ekelund J
    J Clin Psychopharmacol; 2013 Aug; 33(4):472-8. PubMed ID: 23764683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
    Holtmeier W; Holtmann G; Caspary WF; Weingärtner U
    J Clin Gastroenterol; 2007 Jul; 41(6):564-70. PubMed ID: 17577112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Taha AS; McCloskey C; Prasad R; Bezlyak V
    Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease.
    Hongo M; Kinoshita Y; Haruma K
    J Gastroenterol; 2008; 43(6):448-56. PubMed ID: 18600389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect and safety of famotidine for therapy of gastrointestinal bleeding in children].
    Chen FB; Huang XL; Chen J; Wu M; Wang J; Zhou X
    Zhonghua Er Ke Za Zhi; 2005 Jan; 43(1):64-5. PubMed ID: 15796817
    [No Abstract]   [Full Text] [Related]  

  • 8. On the biological treatment of autistic disorder.
    Sher L
    Med Hypotheses; 1999 May; 52(5):489. PubMed ID: 10416959
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment.
    See MC; Birnbaum AH; Schechter CB; Goldenberg MM; Benkov KJ
    Dig Dis Sci; 2001 May; 46(5):985-92. PubMed ID: 11341669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis.
    Simon TJ; Roberts WG; Berlin RG; Hayden LJ; Berman RS; Reagan JE
    Clin Ther; 1995; 17(6):1147-56. PubMed ID: 8750406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data.
    Deutsch SI; Rosse RB; Kendrick KA; Fay-McCarthy M; Collins JP; Wyatt RJ
    Clin Neuropharmacol; 1993 Dec; 16(6):518-24. PubMed ID: 9377587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famotidine in the treatment of acute urticaria.
    Watson NT; Weiss EL; Harter PM
    Clin Exp Dermatol; 2000 May; 25(3):186-9. PubMed ID: 10844490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies.
    Kim J; Ogai A; Nakatani S; Hashimura K; Kanzaki H; Komamura K; Asakura M; Asanuma H; Kitamura S; Tomoike H; Kitakaze M
    J Am Coll Cardiol; 2006 Oct; 48(7):1378-84. PubMed ID: 17010798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.
    Posey DJ; Wiegand RE; Wilkerson J; Maynard M; Stigler KA; McDougle CJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):599-610. PubMed ID: 17069548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
    Vasil'ev IuV; Li IA
    Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.